baber/WOPTO huggingface dataset:
Patent JP-H0653680-B2 (JP)
IPC: A61K31/569
Filed: 1985-10-10
Abstract: The rate and character of human hair growth including androgen-stimulated beard hair growth in intact, sexually mature males is altered by the topical application out of a dermatologically acceptable carrier of a material capable of inhibiting the action of the enzyme ornithine decarboxylase. In a preferred practice of the invention, compositions containing such materials along with anti-androgen material are employed.
Patent JP-H0617729-B2 (JP)
IPC: F23D14/10
Filed: 1987-08-03
Abstract: The process obtains a plurality of small flames which become violet when combusting natural gas. In particular the amount of primary air induced is at least 80 % of the air stoichiometrically required for combustion; the secondary air laps all sides of each single small flame (F) arising from each small group (5) of slots (7, 7') on the burner body (1), in the area where each flame leaves the surface of the burner body (1) so as to swell it making its width at least as big as its height and/or alternatively the contact surface between each flame and the secondary air is increased right from the first steps in combustion, so that each small group (5) creates a small flame with two divergent bladed wings, similar to ''butterfly wings''.
Patent JP-H0665349-B2 (JP)
IPC: A61M35/00
Filed: 1992-03-09
Abstract: A process for continuously manufacturing transdermal therapeutic patches having a backing layer, a pressure-sensitive adhesive drug reservoir layer, and a removable protective layer, whereby loss of active substances during fabrication of the patches is minimized, said process being characterized in that, in a tape-like laminate having a pressure-sensitive adhesive backing layer (1) and a removable protective layer (3), single quadrangular pressure-sensitive adhesive drug reservoir sections (2) are inserted one after the other in the longitudinal direction between the layers (2,3); the clearance between said drug reservoir sections remains constant in the longitudinal direction; their width is calculated such that the backing layer (1) and the removable protective layer (3) project beyond both sides of said sections; the pressure-sensitive adhesive backing layer (1) is first cut by punching in such a way that the punching line (1a) surrounds the individual drug reservoir sections (2) at an evident distance from their outer dimensions; the the resulting lattice-type refuse of the drug-free pressure-sensitive adhesive backing layer (1) is removed; and subsequently the protective layer (3) is cut in the resultant spaces between the drug reservoir sections (2).
Patent JP-4017022-B2 (JP)
IPC: C07C251/54
Filed: 1995-07-28
Granted: 2007-12-05
Abstract: Preparation of O-(2-hydroxyalkyl) oximes of formula (I), (R<1> and R<2> are alkyl or R<1> and R<2> and the common C atom are 5-membered to 7-membered cycloalkyl; R<3> is alkyl) by causing a ketoxime II to react with an olefin oxide III in the presence of a tertiary amine or with a carbonate IV in the presence of a catalyst. The end products (I) are suitable for use as intermediates for crop protection agents.
Patent JP-3458355-B2 (JP)
IPC: C12R1/01
Filed: 1993-07-20
Granted: 2003-10-20
Abstract: A method for increasing both total antibiotic yield the selective production of factor A of the GE 2270 antibiotics consisting in the addition of vitamin B12 or its analogs having vitamin B12-like activity to the fermentation media of (Planobispora rosea) ATCC 53773 or any antibiotic GE 2270 producing mutant or variant thereof.
Patent JP-2916258-B2 (JP)
IPC: H01P7/10
Filed: 1992-05-05
Granted: 1999-07-05
Abstract: The invention relates to a dielectric resonator (3) comprising two cylindrical discs made of a dielectric material. In the invention, the discs (3A,3B) are positioned with their planar surfaces against each other, so that they are radially displaceable with respect to each other for varying the shape of the resonator (3) and for adjusting the resonance frequency (3).
Patent JP-4018752-B2 (JP)
IPC: C07K1/04
Filed: 1997-07-30
Granted: 2007-12-05
Abstract: Novel peptide analogs are disclosed. The novel peptides are conformationally constrained backbone cyclized somatostatin analogs. Methods for synthesizing the somatostatin analogs and for producing libraries of the somatostatin analogs are also disclosed. Furthermore, pharmaceutical compositions comprising somatostatin analogs, and methods of using such compositions in the treatment of endocrine disorders, neoplasms and metabolic disorders are also disclosed.
Patent JP-3704544-B2 (JP)
IPC: B01D65/00
Filed: 1995-09-08
Granted: 2005-10-12
Abstract: PCT No. PCT/AU95/00587 Sec. 371 Date Aug. 8, 1997 Sec. 102(e) Date Aug. 8, 1997 PCT Filed Sep. 8, 1995 PCT Pub. No. WO96/07470 PCT Pub. Date Mar. 14, 1996A method and apparatus for recovering fine solids from a liquid feed suspension is disclosed. The apparatus has an operating cycle including a concentration part of the cycle in which solids present in the feed suspension are concentrated and a backwash part of the cycle in which supply of feed suspension to the concentrator is interrupted, the concentrator comprises a shell (11), and a plurality of elastic, hollow, microporous, polymer fibers (12) being fixed at their ends within the shell (11). Pressurized feed suspension is supplied to the outside of the fibers during said concentration part of the cycle and the filtrate may be withdrawn from the fiber lumens during the operating cycle. During the backwash cycle the concentration part of the cycle is terminated by ceasing supply of feed to said exterior surface of the fibers (12). The shell (11) is then sealed and the remaining filtrate removed from the lumens. A source of fluid under pressure is then applied to said lumens before, at the same time as, or just after opening the shell (11) to atmosphere, to cause explosive decompression through the walls of the fibers (12) whereby the fluid under pressure passes through said walls. The pressure level in said lumens is maintained at a predetermined value for a sufficient time following said decompression to cause substantial portions of solids lodged within and/or on the fiber walls to be dislodged. The dislodged contaminant matter is then washed away by the application of a flow of liquid over the surface of the fiber walls; and the concentration part of the operating cycle is recommended by introducing the supply of feed suspension to said exterior surface of said fibers (12).
Patent JP-4215273-B2 (JP)
IPC: A61K35/30
Filed: 1992-04-22
Granted: 2009-01-28
Abstract: An immunoisolatory vehicle for the implantation into an individual of cells which produce a needed product or provide a needed metabolic function. The vehicle is comprised of a core region containing isolated cells and materials sufficient to maintain the cells, and a permselective, biocompatible, peripheral region free of the isolated cells, which immunoisolates the core yet provides for the delivery of the secreted product or metabolic function to the individual. The vehicle is particularly well-suited to delivery of insulin from immunoisolated islets of Langerhans, and can also be used advantageously for delivery of high molecular weight products, such as products larger than IgG. A method of making a biocompatible, immunoisolatory implantable vehicle, consisting in a first embodiment of a coextrusion process, and in a second embodiment of a stepwise process. A method for isolating cells within a biocompatible, immunoisolatory implantable vehicle, which protects the isolated cells from attack by the immune system of an individual in whom the vehicle is implanted. A method of providing a needed biological product or metabolic function to an individual, comprising implanting into the individual an immunoisolatory vehicle containing isolated cells which produce the product or provide the metabolic function.
Patent JP-3135576-B2 (JP)
IPC: C07H21/04
Filed: 1993-12-07
Granted: 2001-02-19
Abstract: Receptor components for IL-10 are isolated and characterized. The amino acid sequence and nucleic acid encoding various species variants of the receptors are disclosed. Uses of the purified receptor gene and polypeptide are disclosed, including means for screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies. Therapeutic or diagnostic reagents and kits are also provided.
Patent JP-2761494-B2 (JP)
IPC: G01N21/78
Filed: 1991-11-13
Granted: 1998-06-04
Abstract: PCT No. PCT/EP91/02160 Sec. 371 Date Jul. 12, 1993 Sec. 102(e) Date Jul. 12, 1993 PCT Filed Nov. 13, 1991 PCT Pub. No. WO92/08722 PCT Pub. Date May 29, 1992The present invention relates to labelling agents comprising non-proteinaceous boronic acid conjugates having absorption maxima at not less than 600 nm, said label being provided by e.g., an azine, triphenylmethane, cyanine or phthalocyanine dye. The labelling agents are useful in the estimation and quantification of cisdiols such as glycosylated haemoglobin, by virtue of the substantially total absence of overlap with the absorption spectrum of haemoglobin. Oxazine and thiazine dyes exhibiting similar absorption characteristics and containing other activated moieties are similarly useful labelling agents, especially in the presence of haemoglobin.
Patent JP-3118462-B2 (JP)
IPC: A24B15/10
Filed: 1995-01-26
Granted: 2000-12-18
Abstract: A smoking article (10) contains a flavor component retainer obtained by heating and gelling a mixture of a flavor component and a non-gelled glucan and containing heat-irreversibly gelled glucan, and a flavor generation material containing the flavor component retained by this retainer as a combustion smoking raw material (12). Since the flavor component is firmly fixed and retained inside a three-dimensional network structure of gelled glucan, preservability and emission durability of the flavor component can be improved. <MATH>
Patent JP-3871345-B2 (JP)
IPC: B26B19/38
Filed: 1996-11-18
Granted: 2007-01-24
Abstract: A buck converter comprises a load or a rechargeable battery (B), a self-inductance (L2), a diode (D2) and a switching transistor (T1). The current through the switching transistor (T1) is measured by means of a current sensor (Rs) which triggers a monostable multivibrator (MMV) when a given peak current is reached. The monostable multivibrator (MMV) turns off the switching transistor (T1) for a fixed time within which the current through the self-inductance (L2) is supplied to the load (B) via the diode (D2).
Patent JP-3857728-B2 (JP)
IPC: H04L/
Filed: 1997-01-24
Granted: 2006-12-13
Abstract: A method of indicating the length of a mini cells in a mobile telephony network. Non linear coding of a short fixed length field in the header of the mini cell is described. Either an extension bit method or an extension code method is used to extend the length field so as to increase the number of length values available for coding of the mini cell sizes. The length of a mini cell is indicated in the individual mini cell or is indicated indirectly using a CID/length mapping table. Mini cell sizes are changed during a connection and methods are described for doing this. Cell header reading devices for extracting user information of individual mini cells are described. A mobile telephone network using the cell header reading devices is described.
Patent JP-3808103-B2 (JP)
IPC: A61F2/46
Filed: 1997-02-19
Granted: 2006-08-09
Abstract: An interbody fusion device (10') in one embodiment includes a load bearing body (11') defining a hollow interior or chamber (15) for receiving an osteogenic material. In another embodiment, the tapered body is solid and formed of a porous biocompatible material having sufficient structural integrity to maintain the intradiscal space and normal curvature. The material is preferably a porous tantalum composite having a fully interconnected pores to facilitate complete bone tissue ingrowth into the implant. A cap (300) is also provided to block the opening (15a) of the hollow fusion device (10'). The cap (300) includes an occlusion body (301) and an elongated anchor (310). In some embodiments the anchor includes a lip (315) which is engageable to openings (24') in the body wall. Tools are also provided for manipulating caps for interbody fusion devices. In one embodiment the tool includes a cap-engaging tip for engaging a threaded tool hole (320) in the cap (300). <IMAGE>
Patent JP-3608798-B2 (JP)
IPC: C12P41/00
Filed: 1997-04-14
Granted: 2005-01-12
Abstract: The invention belongs to the field of biotechnology. It concerns a biocatalyst, i.e. a dead or living microorganism or a polypeptide, preferably in isolated form, which exhibits acylase enzymatic activity without lipase- or esterase-activity. The biocatalyst is capable of stereoselectively hydrolysing a racemic acylamide which has an aliphatic acyl residue and which is not a derivative of a natural amino acid.
Patent JP-3876002-B2 (JP)
IPC: A61K39/395
Filed: 1998-04-14
Granted: 2007-01-31
Abstract: The present invention provides an anti-human antibody or fragment thereof that is low or not immunogenic in humans. In particular, the antibodies or fragments are directed to human tumor antigens, preferably to the human tumor antigen 17-1A, also known as EpCAM, EGP or GA 733-2. Also provided are pharmaceutical compositions comprising the aforementioned antibodies or fragments thereto.
Patent PL-162076-B2 (PL)
Title: Device for generation of magnetic field
Inventor: BONCZAK BAZYLI
IPC: G09B23/18
Filed: 1990-12-21
Abstract: Instrument for producing a magnetic field, consisting of magnets and pole pieces, characterized in that it has a column of magnets, preferably ferrite magnets, formed of horizontally situated identical rings (1) and, fitted into them, non-ferromagnetic sleeves (2) which are twisted together, and also has parallel steel arms (4, 5) with one end screwed, through non-ferromagnetic sleeves (6, 7) which are fitted into them, into the ends of the column, while pairs of replaceable pole pieces (9) corresponding to each other in shape are slid in identical recesses (10) onto the opposite ends of the arms.<IMAGE>
Patent AU-2001242634-B2 (AU)
Title: Hybridisation beacon and method of rapid sequence detection and discrimination
Inventor: MCDOWELL DAVID GORDON
IPC: G01N33/58
Filed: 2001-03-28
Granted: 2006-06-01
Abstract: A method for detecting specific DNA sequences and discriminating single nucleotide polymorphisms (SNPs) using fluorescently labelled oligonucleotide probes is disclosed. Oligonucleotide probes are labelled with a reporter molecule preferentially attached to an internal nucleotide residue. The fluorescence emission of oligonucleotide probes varies significantly when in single-stranded and double-stranded states despite the absence of quencher moieties, allowing reliable detection of complementary DNA targets. The melting temperature of probe/target duplexes permits discrimination of targets that differ by as little as a single nucleotide residue, such that polymorphic targets may be discriminated by fluorescence quantitation and Tm. The hybridisation probes of this invention have been demonstrated to accurately identify homozygous and heterozygous samples using a single fluorescent oligonucleotide and direct investigation of saliva with hybridisation probes permits ultra-rapid genotypic analysis within 35-40 minutes. Target detection and SNP discrimination assays have been achieved in homogeneous, heterogeneous, 'real-time' and solid-phase formats.
Patent AU-2001250727-B2 (AU)
Title: Reusable grenade cartridge
Inventor: TORSTEN WERNER
IPC: F42B5/02
Filed: 2001-04-25
Granted: 2005-10-20
Abstract: Grenade cartridge adapted to be fired from a firing tube, comprising a projectile, a cartridge and a propellant with primer. The grenade cartridge (1) is rechargeable by having a dividable, two-part cartridge such that a cartridge front portion (3), as seen in the firing direction, is tube shaped and in a first end thereof formed to receive the projectile (2) whereas the other end is formed to be detachably connected with a cartridge rear portion (4), and a separate propellant cartridge (9) with primer is axially supported in opposite directions by the two cartridge portions being mutually connected.
Patent AU-2001275831-B2 (AU)
Title: Vapour deposition
Inventor: LINDEN JOANNES LEONARD
IPC: C23C14/24
Filed: 2001-07-17
Granted: 2006-09-07
Abstract: The invention relates to a process for applying a coating to a substrate wherein the coating is formed of at least two components or elements. In a preferred embodiment, the coating is formed of at least two metals. In accordance with the invention, the coating is applied by vapor deposition under choking conditions. <IMAGE>
Patent AU-2001278188-B2 (AU)
Title: Tyrosine derivatives as phosphatase inhibitors
Inventor: GAUDINO JOHN
IPC: C07D209/16
Filed: 2001-07-05
Granted: 2007-05-17
Abstract: Disclosed are compounds of the Formula Iand pharmaceutically acceptable salts and prodrugs thereof, wherein A, B; R1, R2, R3, R4 and R5 are as defined in the specification.Such compounds are tyrosine phosphatase inhibitors and useful in the treatment or prevention of Type II Diabetes Mellitus. Also encompassed by the invention are formulations comprising the noted compounds, processes for preparing such compounds, a method for treating or preventing Type II Diabetes Mellitus.
Patent AU-2002210862-B2 (AU)
Title: Method for the amplification and optional characterisation of nucleic acids
Inventor: MCCARTHY THOMAS VALENTINE
IPC: C12Q1/682
Filed: 2001-11-01
Granted: 2006-06-08
Abstract: A method for the amplification of a template nucleic acid comprises simultaneously carrying out the steps of reacting a nucleic acid primer with said template nucleic acid, normal DNA precursor nucleotides, at least one modified DNA precursor nucleotide and a DNA polymerase so as to obtain an extended nucleic acid primer, said nucleic acid primer remaining bound to said template; cleaving the modified base-containing extended nucleic acid primer so as to generate a free 3'-OH terminus that is extendible by said DNA polymerase; and repeating steps i) and ii) on DNA fragments thereby generated. The modified precursor nucleotide may be a substrate for a DNA glycosylase or recognised by a 3'-endonuclease and determines the cleavage of the DNA and the site of the cleavage accordingly. The method has significant advantages over existing technologies in that it is more versatile and more flexible with respect to providing a single high throughput process that can be easily adapted to multiple different formats in the fields of DNA detection, quantitation and characterisation.
Patent AU-2002222801-B2 (AU)
Title: Device and method for cleaning a fluid, such as water
Inventor: VELLINGA SJOERD HUBERTUS JOSEF
IPC: C02F3/12
Filed: 2001-11-23
Granted: 2006-12-21
Abstract: A device for cleaning a fluid comprises at least one set of a first membrane cloth and a second membrane cloth, each being permeable to water over substantially their entire length. The membrane cloths are held taut, substantially parallel to one another in a frame delimiting between them a movement path for fluid. The cloths are displaceable with respect to one another between a first position, in which the mutually facing surfaces substantially touch one another, and a second position, in which the cloths lie at a distance from one another and the width of the movement path for the fluid is greater than in the first position. At least one of the cloths, on the side which faces towards the adjacent cloth is provided with grooves or webs for the purpose of forming channels between the cloths in the longitudinal direction of the cloths, in the first position.
Patent AU-2002226039-B2 (AU)
Title: Apparatus and method for heating catalyst for start-up of a compact fuel processor
Inventor: KRAUSE CURTIS
IPC: C10J1/207
Filed: 2001-12-05
Granted: 2007-09-13
Abstract: A reactor module for use in a compact fuel processor, comprising: 
a catalyst bed; a cooling coil positioned substantially within the catalyst bed for removing excess heat during normal operation; and an electrical heating element positioned within the cooling coil, the heating element capable of heating the catalyst to a desired reaction temperature.
Patent AU-2002252689-B2 (AU)
Title: Cut resistant paper and paper articles and method for making same
Inventor: FROASS PETER M
IPC: B42F7/00
Filed: 2002-04-11
Granted: 2006-10-19
Abstract: The specification discloses a method for making a paper material having a reduced tendency to cut human skin. The Method includes providing a papermaking furnish containing cellulosic fibers and from about 0.5 to about 5.0 wt% by weight dry basis expandable microspheres, forming a paperboard web from the papermaking furnish, drying the web, and calendaring the web to a caliper of from about 18.0 mils and a density ranging from about 7.0 to about 12.0 1b/3000ft2/mil. Papers formed according to the method and articles formed therefrom are also disclosed.
Patent AU-2002300920-B2 (AU)
Title: Ladle equipped with gas-blowing device having accumulator cylinder
Inventor: KONDO JYUNYA
IPC: C21C7/072
Filed: 2002-09-06
Granted: 2004-10-07
Abstract: A ladle (1) equipped with a gas blowing device having an accumulator cylinder (7) is provided, which has the capability of suppressing molten metal from penetrating into an injection plug (3) embedded in the ladle (1) and having a high resistance leading to a longer service life of the injection plug (3). The gas-blowing device (5) comprises a main pipe (8) for blowing gas into the ladle (1) via a gas-blowing plug (3) from a positionally independent gas supply source (4); an accumulator cylinder (7) for accumulating the gas supplied through the main pipe (8); and a controller (6). The controller (6) is used for accumulating the gas into the accumulator cylinder (7) when the gas blowing through the main pipe (8) begins or when the gas blowing is carried out, and for starting to blow the gas accumulated in the accumulator cylinder (7) simultaneously with a termination of the gas blowing through the main pipe (8). <IMAGE>
Patent AU-2002308579-B2 (AU)
Title: Method for reducing malodors in hydrotropic compositions
Inventor: MYERS E GARY
IPC: A61L9/00
Filed: 2002-05-01
Granted: 2004-07-15
Abstract: A method for reducing malodors in hydrotropes, such as alkyl aryl sulfonates, is provided that reduces and/or eliminates some or all of the detectable residual odoriferous compounds from hydrotropic compositions using a malodor treatment material, such as, for example, activated carbon. In one aspect of a preferred embodiment of the invention, a malodor treatment material enables the reduction and/or elimination of residual odoriferous compounds from hydrotropic compositions while keeping intact the active hydrotrope solids.
Patent AU-2003210854-B2 (AU)
Title: Dermal access member
Inventor: SUTTER DIANE E
IPC: A61M35/00
Filed: 2003-02-04
Granted: 2008-05-29
Abstract: An apparatus for delivering or withdrawing a fluid through at least one layer of the skin is provided. A device (10) includes a body (12) having a top face (20), a bottom face (18), a side edge (16) and at least one channel (22). The bottom face (18) includes a first surface area (28) and a second surface area (30) adjacent to and recessed at a first distance from the first surface area (28). The bottom face (18) further includes at least one raised protrusion (32) disposed on the second surface area (30). The protrusion (32) has a height from the first surface (28) greater than the first distance. At least one dermal-access member (14) is provided in the protrusion (32) and is in fluid communication with the channel (22) to deliver or withdraw the fluid. The dermal-access member (14) extends at least 1 mm from the protrusion (32). A mechanism drives the device (10) against the skin at a calculated speed of about 6 m/s to about 18 m/s.